Predictive value of CHA2DS2-VASc, CHA2DS2-VASc-HS and CHA2DS2-VASc -HST(CHH-T) score for thrombolytic failure in patient with ST segment elevation acute myocardial infarction from Chiang Mai cardiac networks

Faculty of medicine, Chiang Mai university0 个研究点目标入组 327 人开始时间: 2022年3月21日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Age > 18 years
•2. Diagnosed ST-segment elevate acute myocardial infarction who received non-specific thrombolytic agent (SK) based on the decision of physician according to recommended doses from Chiang Mai cardiac networks

•1. No following electrocardiogram from any cause
•2. Hemodynamic and/or electrical instability
•3. Death before result interpretation
•4. Contraindication to a thrombolytic agent such as previous intracranial hemorrhage or stroke of unknown origin at anytime, ischemic stroke in the preceding 6 months, central nervous system damage or neoplasms or arteriovenous malformation, recent major trauma/surgery/head injury (within the preceding month), gastrointestinal bleeding within the past month, known bleeding disorder, aortic dissection, non-compressible puncture in the past 24 hours (e.g. liver biopsy, lumbar puncture)

发起方